Autolus Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference

On March 4, 2019 Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, reported that Dr. Christian Itin, chairman and chief executive officer, will present at the Cowen and Company 39th Annual Healthcare Conference in Boston, on March 11, at 2:10 pm ET (Press release, Autolus, MAR 4, 2019, https://autolus.gcs-web.com/news-releases/news-release-details/autolus-therapeutics-present-cowen-and-company-39th-annual [SID1234550822]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available on the investor relations section of the company’s website: View Source An archived replay will be available on the company’s website for a period of 90 days after the conference.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!